Literature DB >> 10356101

Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials.

T J DeGraba1, J M Hallenbeck, K D Pettigrew, A J Dutka, B J Kelly.   

Abstract

BACKGROUND AND
PURPOSE: The objective was to determine the occurrence of neurological changes during the first 48 hours after acute stroke as it relates to initial stroke severity.
METHODS: The National Institutes of Health Stroke Scale (NIHSS) was performed serially for the first 48 hours on 127 consecutive ischemic stroke patients (129 strokes) admitted to the neuroscience intensive care unit. Incidence of stroke progression (a >/=3-point increase on the NIHSS) was recorded and analysis performed to determine its association with initial stroke severity and other demographic and physiological variables. Deficit resolution by 48 hours, defined as an NIHSS score of 0 or 1, measured the frequency of functional recovery predicted by the initial deficit.
RESULTS: Overall progression was noted in 31% of events (40/129). Applying Bayes' solution to the observed frequency of worsening, the greatest likelihood of predicting future patient progression occurs with stratification at NIHSS scores of </=7 and >7. Patients with an initial NIHSS of </=7 experienced a 14.8% (13/88) worsening rate versus a those with a score of >7 with a 65.9% (27/41) worsening rate (P<0.000005). Forty-five percent (40/88) of those with an initial score of </=7 were functionally normal at 48 hours, whereas only 2.4% (1/41) of those with scores of >7 returned to a normal examination within this period (chi2, P<0.000005).
CONCLUSIONS: This study suggests that the early clinical course of the neurological deficit after acute stroke is dependent on the initial stroke severity and that a dichotomy in early outcome exists surrounding an initial NIHSS score of 7. These findings may have significant implications for the design and patient stratification in treatment protocols with respect to primary clinical outcome.

Entities:  

Mesh:

Year:  1999        PMID: 10356101     DOI: 10.1161/01.str.30.6.1208

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  36 in total

1.  Truths about the NINDS study: setting the record straight.

Authors:  Jeffrey Mann
Journal:  West J Med       Date:  2002-05

2.  What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke?

Authors:  James E Siegler; Amelia K Boehme; Andre D Kumar; Michael A Gillette; Karen C Albright; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-06-21       Impact factor: 2.136

Review 3.  Why have neuro-protectants failed?: lessons learned from stroke trials.

Authors:  K W Muir; Ph A Teal
Journal:  J Neurol       Date:  2005-08-25       Impact factor: 4.849

4.  Combining MRI with NIHSS thresholds to predict outcome in acute ischemic stroke: value for patient selection.

Authors:  P W Schaefer; B Pulli; W A Copen; J A Hirsch; T Leslie-Mazwi; L H Schwamm; O Wu; R G González; A J Yoo
Journal:  AJNR Am J Neuroradiol       Date:  2014-09-25       Impact factor: 3.825

5.  Time to Neurological Deterioration in Ischemic Stroke.

Authors:  James E Siegler; Karen C Albright; Alexander J George; Amelia K Boehme; Michael A Gillette; Andre D Kumar; Monica Aswani; Sheryl Martin-Schild
Journal:  Med Student Res J       Date:  2017

6.  Neuroprotection by Chlorpromazine and Promethazine in Severe Transient and Permanent Ischemic Stroke.

Authors:  Xiaokun Geng; Fengwu Li; James Yip; Changya Peng; Omar Elmadhoun; Jiamei Shen; Xunming Ji; Yuchuan Ding
Journal:  Mol Neurobiol       Date:  2016-11-28       Impact factor: 5.590

7.  Imaging Biomarkers for Intra-arterial Stroke Therapy.

Authors:  Olvert A Berkhemer; Shervin Kamalian; R Gilberto González; Charles B L M Majoie; Albert J Yoo
Journal:  Cardiovasc Eng Technol       Date:  2013-12-01       Impact factor: 2.495

8.  Relationships between angiographic findings and National Institutes of Health stroke scale score in cases of hyperacute carotid ischemic stroke.

Authors:  Makoto Nakajima; Kazumi Kimura; Toshiyasu Ogata; Tatsuro Takada; Makoto Uchino; Kazuo Minematsu
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

9.  [Worsening in patients treated in acute stroke units--results of the Austrian Stroke Unit Registry].

Authors:  Julia Ferrari; Agathe Flamm-Horak; Agnes Lischka-Lindner; Michael Knoflach; Stefan Schnabl; Wilfried Lang
Journal:  Wien Med Wochenschr       Date:  2008

10.  Preliminary efficacy report of a novel thrombolytic agent for acute ischaemic stroke within a 5-hour window.

Authors:  A-Ching Chao; Michael Mu-Huo Teng; Chih-Ping Chung; Hsing-Yu Weng; Yen-Yu Chen; Fu-Yi Yang; Lee-Min Wang; Han-Hwa Hu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.